CARPL.ai, the world’s largest radiology AI marketplace and enterprise platform, today announced a Series A round of USD 10 million led by International Finance Corporation (IFC), the private sector arm of the World Bank Group, with participation from Stellaris Venture Partners and other investors. The funding will accelerate CARPL’s mission to help healthcare providers adopt AI in a meaningful and safe manner. 

CARPL is trusted by the world’s largest and most prestigious healthcare organizations, including four of the world’s top five private radiology groups. It is also being used by many governments, including Brazil, India, Singapore, Spain and the UAE. 

Medical imaging generates more than 80% of healthcare data, as imaging demand continues to outpace radiologist capacity. Although more than 1,000 FDA-cleared radiology AI applications are available today, adoption remains fragmented. Healthcare organizations are forced to evaluate, integrate, and monitor dozens of standalone AI products independently, creating significant operational and IT complexity. In short, while the AI applications exist, the governance of these applications does not. 

Through a single integration with CARPL, healthcare providers gain access to the world’s largest radiology AI marketplace with more than 300 AI applications from over 100 partners. In addition to this, the CARPL platform also enables its customers to build, test, deploy, and monitor AI across clinical workflows while remaining vendor-neutral and infrastructure-agnostic. 

The investment will support continued product innovation, expansion of CARPL’s global partner ecosystem, and commercial growth across North America, LATAM, Europe, Asia-Pacific, and emerging markets. The partnership also reflects a shared focus on advancing digital health innovation through CARPL’s model of building high-skill engineering, product development, and AI capabilities in India for deployment to healthcare providers around the world. 

“Our mission is to ensure that clinicians can confidently utilize the absolute best AI technology available for their patients. Over the past few years, we have built the world’s largest radiology AI marketplace, integrated deeply with leading enterprise PACS providers, and earned the trust of some of the largest healthcare enterprises across the globe, who rely on us as their partner in their AI and automation journeys. We are privileged to have International Finance Corporation as a partner as we grow across the world.” said Dr. Vidur Mahajan, Chief Executive Officer of CARPL.ai. 

While CARPL has started in the domain of radiology, which has 1000s of AI applications waiting to be deployed, the goal is to become the integration, utilization and procurement layer for all clinical AI that goes into healthcare organizations. “We will soon move beyond medical imaging into the domains of pathology, genomics and general medicine, and one day, if there is a robotic surgeon somewhere using AI to perform surgery, we hope that it will be running through CARPL,” Dr Mahajan added. 

Farid Fezoua, Global Director for Private Equity and Venture Capital, International Finance Corporation said, “Expanding access to high-quality diagnostics in emerging markets is one of the most pressing priorities in global healthcare, and AI is becoming a critical part of the solution. CARPL.ai is building the digital infrastructure that enables healthcare providers to adopt AI at scale, improving diagnostic quality and expanding access to care. IFC is proud to support a company that combines world-class innovation with India’s deep technology talent, creating high-skilled jobs while addressing a critical global healthcare need. This investment reflects World Bank Group’s commitment to advancing innovation, strengthening digital health ecosystems, and ensuring the benefits of AI reach patients in emerging markets and underserved communities worldwide.” 

Alok Goyal, Partner, Stellaris Venture Partners, said “We are excited to see CARPL’s remarkable journey since our initial investment and to watch our original thesis play out so strongly. Over the past few years, the team has executed exceptionally well, earning the trust of leading healthcare institutions worldwide, building deep partnerships with leading PACS providers, and enabling millions of patient scans through its platform. This is a testament to the vision, ambition, and execution of Dr. Vidur Mahajan and his team, and we’re excited to continue supporting CARPL as it builds the foundational infrastructure for AI-powered healthcare globally.”